FDA Risk For Portola Pharma's Thrombosis Treatment Sends Morgan Stanley To Sideline
March 01, 2018 at 11:01 AM EST
Portola Pharmaceuticals Inc (NASDAQ: PTLA) plunged Thursday after the release of its fourth-quarter results. The company reported a ...
